We presented our long investment thesis on Regeneron (NASDAQ:REGN) to subscribers of our premium Seeking Alpha investment research service, Vasuda Healthcare Analytics, on December 7. Shares rallied about 7% in a week before a pullback. We consider this pullback as another excellent opportunity to start establishing a long position in this blue-chip large-cap biotechnology company.
Regeneron common stock price chart
We compared some key financial metrics for Regeneron and Celgene (NASDAQ:CELG), which are given in the table below.
penny stock message boards: Renewable Energy Group, Inc.(REGI)
- [By Manikandan Raman]
There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).
penny stock message boards: Summer Infant Inc.(SUMR)
- [By Peter Graham]
A long term performance chart shows shares of Childrens Placeoutperforming last year before leveling off into a range while mid cap peerCarter’s, Inc (NYSE: CRI) is nearing previous highs againand small cap Summer Infant, Inc (NASDAQ: SUMR) is well below previous highs:
penny stock message boards: AAON Inc.(AAON)
- [By WWW.MONEYSHOW.COM]
Aaon Inc. (AAON) is an Oklahoma-based, family-owned and operated firm, with 23.54% insider ownership. It is an excellent business to own for the long term.
penny stock message boards: Monsanto Company(MON)
- [By Shanthi Rexaline]
Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers
Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.
- [By Chris Lange]
Monsanto Co.’s (NYSE: MON) latest quarterly earnings report is expected on Wednesday. The consensus analyst estimates are $1.77 in earnings per share (EPS) and $4.17 billion in revenue. Shares closed trading most recently at $117.02, in a 52-week range of $97.35 to $118.15. The consensus price target is $122.66.
- [By Maxx Chatsko]
BeforeBayer(NASDAQOTH: BAYRY)arrived onto the scene, I viewedMonsanto(NYSE: MON)as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio, the pending acquisition throws a wrench in anyone’s plans to start or add to a position. Uncertainty stemming from the merger provides several terrible reasons to buy Monsanto at this time.
penny stock message boards: Revlon, Inc.(REV)
- [By Lee Jackson]
These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).
- [By Jeremy Bowman]
Shares of Revlon, Inc.(NYSE:REV) surged last month after the company announced a restructuring plan. According to data from S&P Global Market Intelligence, the stock gained 15%. The bulk of the increase came in the middle of the month when the restructuring plan was announced.